LeMaitre Vascular, Inc. (LMAT) Misses Q1 EPS by 2c
LeMaitre Vascular, Inc. (NASDAQ: LMAT) reported Q1 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $13.9 million versus the consensus estimate of $13.7 million.
LeMaitre Vascular, Inc. sees Q2 2012 revenue of $14.2 million, versus the consensus of $14.4 million.
LeMaitre Vascular, Inc. sees FY2012 revenue of $57 million, versus the consensus of $57.3 million.
LeMaitre Vascular, Inc. sees Q2 2012 revenue of $14.2 million, versus the consensus of $14.4 million.
LeMaitre Vascular, Inc. sees FY2012 revenue of $57 million, versus the consensus of $57.3 million.
For earnings history and earnings-related data on LeMaitre Vascular, Inc. (LMAT) click here.